Filing Flows › Comparisons › SXTP vs DARE
60 Degrees Pharmaceuticals vs Dare Bioscience: SXTP and DARE compared
60 Degrees Pharmaceuticals is the larger company: $208K of revenue in its latest quarter (Q2 2026) against $188K for Dare Bioscience (Q2 2026).
Where the money goes: SXTP and DARE
60 Degrees Pharmaceuticals (SXTP) · Q2 2026
60 Degrees Pharmaceuticals, Q2 2026: revenue $208K (+106% year over year), net loss $2.3M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
Dare Bioscience (DARE) · Q2 2026
Dare Bioscience, Q2 2026: revenue $188K, net loss $3.0M, operating cash flow −$6.8M. The chart follows the revenue to costs, profit and cash.
| 60 Degrees Pharmaceuticals (SXTP) | Dare Bioscience (DARE) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $208K | $188K |
| Revenue growth, Y/Y | +106% | — |
| Operating margin | n/m | n/m |
| Net earnings | −$2.3M | −$3.0M |
| Operating cash flow | −$2.2M | −$6.8M |
Questions
Which is bigger, 60 Degrees Pharmaceuticals or Dare Bioscience?
60 Degrees Pharmaceuticals is the larger company: $208K of revenue in its latest quarter (Q2 2026) against $188K for Dare Bioscience (Q2 2026).
More: 60 Degrees Pharmaceuticals earnings · how 60 Degrees Pharmaceuticals makes money · Dare Bioscience earnings · how Dare Bioscience makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.